The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan.

Impact: Immediate Savings to Requesting Rebates WATKINSVILLE, GA / ACCESS Newswire / October 28, 2025 / Rural hospitals in the 340B program are about to feel a new financial pressure. On January 1, ...

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

The American Society of Health-System Pharmacists is urging lawmakers to protect the 340B Drug Pricing Program, warning that changes to the discount model could destabilize safety-net hospitals. In an ...

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...

Lawmakers across the country are working through bills written to shield a growing source of revenue for hospital systems and ...

Court rejects AbbVie 340B restrictions, upholding Colorado law protecting contract pharmacies under the 340B Drug Pricing Program.

Former Congressional Budget Office Director Dan Crippen argues the 340B discount program is overdue for reform.

Drug companies are more likely than hospitals to violate 340B regulations, according to a recent American Hospital Association report. The 340B Drug Pricing Program has been under constant attack on ...

Drugmaker AbbVie sued the state in June because of Senate Bill 71, which forbade drug companies from limiting how many ...

On October 31, 2025, the Centers for Medicare & Medicaid Services (CMS) issued the physician fee schedule (PFS) final rule for calendar year (CY) ...

Drug companies are at it again. They will not relent in their multiyear campaign to dismantle the 340B Drug Pricing Program. Drug companies are at it again. They will not relent in their multiyear ...